Prevalence and risk factors for suicidal ideation in a multiple sclerosis population

Journal of Psychosomatic Research

Volumn 76, Issue 4, 2014, Pages 312-316

  Viner, Rebecca ^a   Patten, Scott B ^a,b   Berzins, Sandra ^a   Bulloch, Andrew G M ^a,b   Fiest, Kirsten M ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Coping; Depression; Longitudinal studies; Multiple sclerosis; Suicidal ideation

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER DISEASE; CONTROLLED STUDY; COPING BEHAVIOR; DEPRESSION; DISEASE ASSOCIATION; DYSPHAGIA; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PATIENT HEALTH QUESTIONNAIRE BRIEF 9; POPULATION RISK; PREVALENCE; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; SELF CONCEPT; SELF REPORT; SHORT BOWEL SYNDROME; SPEECH DISORDER; SUICIDAL IDEATION; SURVIVAL RATE; TASK ORIENTED COPING; TASK PERFORMANCE;

COPING; DEPRESSION; LONGITUDINAL STUDIES; MULTIPLE SCLEROSIS; SUICIDAL IDEATION;

ADULT; DEPRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PREVALENCE; QUESTIONNAIRES; REGISTRIES; RISK FACTORS; SUICIDAL IDEATION; SUICIDE, ATTEMPTED; YOUNG ADULT;

EID: 84895930526     PISSN: 00223999     EISSN: 18791360     Source Type: Journal    
DOI: 10.1016/j.jpsychores.2013.12.010     Document Type: Article

References (39)

1. Sadovnick AD, Remick RA, Allen J, Swartz E, Yee IML, Eisen K, et al. Depression and multiple sclerosis. Neurology 1996, 46:628-632.
2. Joffe RT, Lippert GP, Gray TA, Sawa G, Horvath Z Mood disorders and multiple sclerosis. Arch Neurol 1987, 44:376-378.
3. Minden SL, Orav J, Reich P Depression in multiple sclerosis. Gen Hosp Psychiatry 1987, 9:426-434.
4. Patten SB, Beck CA, Williams JVA, Barbui C, Metz L Major depression in multiple sclerosis: a population-based perspective. Neurology 2003, 61:1524-1527.
5. Korostil M, Feinstein A Anxiety disorders and their clinical correlates in multiple sclerosis patients. Mult Scler 2007, 13:67-72.
6. Patten SB, Svenson LW, Metz LM Psychotic disorders in MS: population-based evidence of an association. Neurology 2005, 1123-1125.
7. Rao SM, Leo GJ, Bernardin L, Unverzagt F Cognitive dysfunction in multiple sclerosis. 1. Frequency, patterns, and prediction. Neurology 1991, 41:685-691.
8. Kessler RC, Borges G, Walters EE Prevalence of and risk factors for lifetime suicide attempts in the National Comorbidity Survey. Arch Gen Psychiatry Jul 1999, 56:617-626.
9. Kroenke K, Spitzer RL, Williams JBW The PHQ-9. Validity of a brief depression severity measure. J Gen Intern Med 2001, 16:606-613.
10. Kroenke K, Spitzer RL The PHQ-9: a new depression diagnostic and severity measure. Psychiatr Ann 2002, 32:1-7.
11. Brønnum-Hansen H, Stenager E, Stenager EN, Koch-Henriksen N Suicide among Danes with multiple sclerosis. J Neurol Neurosurg Psychiatry 2005, 76:1457-1459.
12. Koch-Henriksen N, Bronnum-Hansen H, Stenager E Underlying cause of death in Danish patients with multiple sclerosis: results from the Danish Multiple Sclerosis Registry. J Neurol Neurosurg Psychiatry 1998, 65:56-59.
13. Stenager EN, Stenager E, Koch-Henriksen N, Bronnum-Hansen H, Hyllested K, Jensen K, et al. Suicide and multiple sclerosis: an epidemiological investigation. J Neurol Neurosurg Psychiatry 1992, 55:542-545.
14. Simon GE, Rutter CM, Peterson D, Oliver M, Whiteside U, Operskalski B, et al. Does response on the PHQ-9 depression questionnaire predict subsequent suicide attempt or suicide death?. Psychiatr Serv Dec 1 2013, 64:1195-1202.
15. Pompili M, Forte A, Palermo M, Stefani H, Lamis DA, Serafini G, et al. Suicide risk in multiple sclerosis: a systematic review of current literature. J Psychosom Res Dec 2012, 73:411-417.
16. Turner AP, Williams RM, Bowen JD, Kivlahan DR, Haselkorn JK Suicidal ideation in multiple sclerosis. Arch Phys Med Rehabil Aug 2006, 87:1073-1078.
17. Gaskill A, Foley FW, Kolzet J, Picone MA Suicidal thinking in multiple sclerosis. Disabil Rehabil 2011, 33:1528-1536.
18. Feinstein A Multiple sclerosis, depression, and suicide. Clinicians should pay more attention to psychopathology. BMJ 1997, 315:691-692.
19. Feinstein A An examination of suicidal intent in patients with multiple sclerosis. Neurology 2002, 59:674-678.
20. Kroenke K, Spitzer RL, Williams JB, Lowe B The Patient Health Questionnaire Somatic, Anxiety, and Depressive Symptom Scales: a systematic review. Gen Hosp Psychiatry Jul 2010, 32:345-359.
21. Spitzer RL, Kroenke K, Williams JBW, The Patient Health Questionnaire Primary Care Study Group Validation and utility of a self-report version of the PRIME-MD. The PHQ Primary Care Study. JAMA 1999, 282:1737-1744.
22. Sjonnesen K, Berzins S, Fiest KM, Bulloch AGM, Metz LM, Thombs BD, et al. Evaluation of the 9-item Patient Health Questionnaire (PHQ-9) as an assessment instrument for symptoms of depression in patients with multiple sclerosis. Postgrad Med Sep 2012, 124:69-77.
23. Kroenke K, Strine TW, Spitzer RL, Williams JB, Berry JT, Mokdad AH The PHQ-8 as a measure of current depression in the general population. J Affect Disord Apr 2009, 114:163-173.
24. Razykov I, Hudson M, Baron M, Thombs BD Utility of the Patient Health Questionnaire-9 to assess suicide risk in patients with systemic sclerosis. Arthritis Care Res (Hoboken) May 2013, 65:753-758.
25. Razykov I, Ziegelstein RC, Whooley MA, Thombs BD The PHQ-9 versus the PHQ-8-is item 9 useful for assessing suicide risk in coronary artery disease patients? Data from the Heart and Soul Study. J Psychosom Res Sep 2012, 73:163-168.
26. Endler NS, Parker JD Assessment of multidimensional coping: task, emotion, and avoidance strategies. Psychol Assess 1994, 6:50-60.
27. Chen G, Gully SM, Eden D Validation of a new general self-efficacy scale. Organ Res Methods 2001, 4:62-83.
28. Bernstein DP, Stein JA, Newcomb MD, Walker E, Pogge D, Ahluvalia T, et al. Development and validation of a brief screening version of the Childhood Trauma Questionnaire. Child Abuse Negl Feb 2003, 27:169-190.
29. Bernstein DP, Fink L, Handelsman L, Foote J, Lovejoy M, Wenzel K, et al. Initial reliability and validity of a new retrospective measure of child abuse and neglect. Am J Psychiatry Aug 1994, 151:1132-1136.
30. Dahlem NW, Zimet GD, Walker RR The Multidimensional Scale of Perceived Social Support: a confirmation study. J Clin Psychol Nov 1991, 47:756-761.
31. Spitzer RL, Kroenke K, Williams JB, Lowe B A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med May 22 2006, 166:1092-1097.
32. Stata, version 12.1 [computer program] 2012, Version 12.0, Stata Corporation, College Station, TX.
33. Nezu AM, Nezu CM, Felgoise SH, McClure KS, Houts PS Project Genesis: assessing the efficacy of problem-solving therapy for distressed adult cancer patients. J Consult Clin Psychol Dec 2003, 71:1036-1048.
34. Walker J, Hansen CH, Butcher I, Sharma N, Wall L, Murray G, et al. Thoughts of death and suicide reported by cancer patients who endorsed the "suicidal thoughts" item of the PHQ-9 during routine screening for depression. Psychosomatics Sep 2011, 52:424-427.
35. Patten SB, Schopflocher D Longitudinal epidemiology of major depression as assessed by the Brief Patient Health Questionnaire (PHQ-9). Compr Psychiatry Jan 2009, 50:26-33.
36. Posner K, Brown GK, Stanley B, Brent DA, Yershova KV, Oquendo MA, et al. The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults. Am J Psychiatry Dec 2011, 168:1266-1277.
37. Beck AT, Steer RA, Kovacs M, Garrison B Hopelessness and eventual suicide: a 10 year prospective study of patients hospitalized with suicidal ideation. Am J Psychiatry 1985, 142:559-563.
38. Beck AT, Brown B, Berchick RJ, Stewart BL, Steer RA Relationship between hopelessness and ultimate suicide: a replication with psychiatric outpatients. Am J Psychiatry 1990, 147:190-195.
39. Patten SB, Metz LM Interferon β-1a and depression in secondary progressive MS: data from the SPECTRIMS Trial. Neurology 2002, 59:746.